Recall Notices

After notification of any recall, Express Scripts will continue processing new and refill prescriptions with product from non-recalled lots or manufacturers, if available. Please visit the U.S. Food and Drug Administration (FDA) website for the most up-to-date information on drug safety and recalls.

Medical Device Correction for Omnipod 5 Pods
March 23, 2026
On March 12, 2026, Insulet Corporation initiated a voluntary medical device correction of certain Omnipod® 5 Pods.
Ipsen Voluntarily Withdraws Tazverik
March 17, 2026
On March 9, 2026, Ipsen initiated a voluntary withdrawal of Tazverik® (tazemetostat) oral tablets from the US market, effective immediately, for all approved indications.
Webcol Alcohol Prep Pads Recalled
March 09, 2026
On March 3, 2026, Cardinal Health issued a voluntary recall of select lots of Webcol™ Large Alcohol Prep Pads
Udenyca Recalled
March 09, 2026
On Feb. 26, 2026, the FDA issued a class I recall for multiple lots of Accord BioPharma’s Udenyca® (pegfilgrastim cbqv) injection, 6mg/0.6mL single dose prefilled syringes.
Urgent Correction Issued for TRUE METRIX Instructions
March 04, 2026
Summary: On Feb. 6, 2026, Trividia Health initiated an Urgent Medical Device Correction for TRUE METRIX® Blood Glucose Monitoring Systems
One Lot of Adbry Recalled
February 25, 2026
On Feb. 12, 2026, LEO Pharma initiated a voluntary US recall of Adbry® (tralokinumab ldrm) 300 mg/2mL single dose autoinjector.
FreeStyle Libre 3 Sensors Recalled
December 16, 2025
On Nov. 24, 2025, Abbott Diabetes Care initiated a voluntary recall of select lots of the FreeStyle Libre 3 continuous glucose monitoring sensor.
Famotidine Recalled
November 17, 2025
On Nov. 6, 2025, Fresenius Kabi initiated a voluntary nationwide recall of three lots of famotidine injection, USP, 20mg per 2mL (10mg per mL).
Gammaked Recalled
November 17, 2025
On Nov. 6, 2025, Grifols Therapeutics initiated a voluntary recall of one lot of Gammaked® (immune globulin injection [human]).
Gamunex-C Recalled
October 10, 2025
Grifols Therapeutics LLC issued a voluntary withdrawal of two lots of Gamunex-C® (immune globulin injection [human], 10%) on Sept. 30, 2025, following a rise in reported hypersensitivity reactions associated with the affected vials.

The information on this site is not intended to take the place of your doctor or other healthcare professionals. It is a resource to help you make the best decisions and get the most from the medical services available to you. A licensed physician should be consulted for diagnosis and treatment of all medical conditions.